The Diagnosis of Sarcoidosis

Clinics in Chest Medicine

Volumn 29, Issue 3, 2008, Pages 415-427

  Judson, Marc A ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ANAMNESIS; B CELL LYMPHOMA; BIOPSY; CLINICAL FEATURE; DEMOGRAPHY; DIAGNOSTIC PROCEDURE; GRANULOMA; HUMAN; KVEIM TEST; LABORATORY DIAGNOSIS; LUNG DISEASE; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; RADIOGRAPHY; REVIEW; SARCOIDOSIS;

BIOPSY; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; HUMANS; SARCOIDOSIS;

EID: 44649191248     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2008.03.009     Document Type: Review

References (43)

1. Hunninghake G.W., Costabel U., Ando M., et al. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 16 (1999) 149-173
2. Gordis L. Sarcoidosis. Epidemiology of chronic lung diseases in children (1973), Johns Hopkins University Press, Baltimore (MD) p. 53-78
3. Milman N., and Selroos O. Pulmonary sarcoidosis in the Nordic countries 1950-1982. Epidemiology and clinical picture. Sarcoidosis 7 (1990) 50-57
4. Rybicki B.A., Major M., Popovich Jr. J., et al. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 145 (1997) 234-241
5. Winterbauer R.H., Belic N., and Moores K.D. Clinical interpretation of bilateral hilar adenopathy. Ann Intern Med 78 (1973) 65-71
6. Reich J.M., Brouns M.C., O'Connor E.A., et al. Mediastinoscopy in patients with presumptive stage I sarcoidosis: a risk/benefit, cost/benefit analysis. Chest 113 (1998) 147-153
7. Rybicki B.A., Iannuzzi M.C., Frederick M.M., et al. Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med 164 (2001) 2085-2091
8. Newman L.S., Rose C.S., Bresnitz E.A., et al. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med 170 (2004) 1324-1330
9. Baughman R.P., Teirstein A.S., Judson M.A., et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 164 (2001) 1885-1889
10. Sheffield E.A. Pathology of sarcoidosis. Clin Chest Med 18 (1997) 741-754
11. Lynch III J.P., Kazerooni E.A., and Gay S.E. Pulmonary sarcoidosis. Clin Chest Med 18 (1997) 755-785
12. Lieberman J. Elevation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis. Am J Med 59 (1975) 365-372
13. In: Studdy P.R., and James D.G. (Eds). The specificity and sensitivity of serum angiotensin-converting enzyme in sarcoidosis and other diseases (1983), Pergamon Press, Paris
14. Dawson W.B., and Muller N.L. High-resolution computed tomography in pulmonary sarcoidosis. Semin Ultrasound CT MR 11 (1990) 423-429
15. Spaide R.F., and Ward D.L. Conjunctival biopsy in the diagnosis of sarcoidosis. Br J Ophthalmol 74 (1990) 469-471
16. Gilman M.J., and Wang K.P. Transbronchial lung biopsy in sarcoidosis. An approach to determine the optimal number of biopsies. Am Rev Respir Dis 122 (1980) 721-724
17. Shorr A.F., Torrington K.G., and Hnatiuk O.W. Endobronchial biopsy for sarcoidosis: a prospective study. Chest 120 (2001) 109-114
18. Poe R.H., Israel R.H., Utell M.J., et al. Probability of a positive transbronchial lung biopsy result in sarcoidosis. Arch Intern Med 139 (1979) 761-763
19. Koonitz C.H., Joyner L.R., and Nelson R.A. Transbronchial lung biopsy via the fiberoptic bronchoscope in sarcoidosis. Ann Intern Med 85 (1976) 64-66
20. Garwood S., Judson M.A., Silvestri G., et al. Endobronchial ultrasound for the diagnosis of pulmonary sarcoidosis. Chest 132 (2007) 1298-1304
21. Wong M., Yasufuku K., Nakajima T., et al. Endobronchial ultrasound: new insight for the diagnosis of sarcoidosis. Eur Respir J 29 (2007) 1182-1186
22. Nagai S., and Izumi T. Bronchoalveolar lavage. Still useful in diagnosing sarcoidosis?. Clin Chest Med 18 (1997) 787-797
23. Rosen Y. Pathology of sarcoidosis. Semin Respir Crit Care Med 28 (2007) 36-52
24. Schilstra A., Rottoli P., Jacobs J.A., et al. Case studies to explore the pitfalls in the diagnosis of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 23 (2006) 135-140
25. Adams D.O. The biology of the granuloma. In: Ioachim H.L. (Ed). Pathology of granulomas (1983), Raven, New York 1-20
26. Muller-Quernheim J., Gaede K.I., Fireman E., et al. Diagnoses of chronic beryllium disease within cohorts of sarcoidosis patients. Eur Respir J 27 (2006) 1190-1195
27. Israel H.L., and Goldstein R.A. Hepatic granulomatosis and sarcoidosis. Ann Intern Med 79 (1973) 669-678
28. Merrill P.T., Kim J., Cox T.A., et al. Uveitis in the southeastern United States. Curr Eye Res 16 (1997) 865-874
29. Judson M.A., Baughman R.P., Teirstein A.S., et al. Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS Research Group. A Case Control Etiologic Study of Sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 16 (1999) 75-86
30. Siltzbach L.E. The Kveim test in sarcoidosis. A study of 750 patients. JAMA 178 (1961) 476-482
31. Harris K.M., McConnochie K., and Adams H. The computed tomographic appearances in chronic berylliosis. Clin Radiol 47 (1993) 26-31
32. Fireman E., Haimsky E., Noiderfer M., et al. Misdiagnosis of sarcoidosis in patients with chronic beryllium disease. Sarcoidosis Vasc Diffuse Lung Dis 20 (2003) 144-148
33. Middleton D.C., Lewin M.D., Kowalski P.J., et al. The BeLPT: algorithms and implications. Am J Ind Med 49 (2006) 36-44
34. Rossman M.D., Kern J.A., Elias J.A., et al. Proliferative response of bronchoalveolar lymphocytes to beryllium. A test for chronic beryllium disease. Ann Intern Med 108 (1988) 687-693
35. Judson M.A. Gastrointesinal, hepatic, and splenic involvement with sarcoidosis. Semin Respir Crit Care Med 23 (2002) 529-541
36. Lewis P.J., and Salama A. Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis. J Nucl Med 35 (1994) 1647-1649
37. Kaira K., Oriuchi N., Otani Y., et al. Diagnostic usefulness of fluorine-18-alpha-methyltyrosine positron emission tomography in combination with 18F-fluorodeoxyglucose in sarcoidosis patients. Chest 131 (2007) 1019-1027
38. Manouvrier-Hanu S., Puech B., Piette F., et al. Blau syndrome of granulomatous arthritis, iritis, and skin rash: a new family and review of the literature. Am J Med Genet 76 (1998) 217-221
39. Kurokawa T., Kikuchi T., Ohta K., et al. Ocular manifestations in Blau syndrome associated with a CARD15/Nod2 mutation. Ophthalmology 110 (2003) 2040-2044
40. Brinker H. Granulomatous lesions of unknown significance: the GLUS syndrome. In: James DG, editor. Sarcoidosis and other granulomatous disorders. Philadelphia: W.B. Saunders; 1994. p. 69-86.
41. Churg A., Carrington C.B., and Gupta R. Necrotizing sarcoid granulomatosis. Chest 76 (1979) 406-413
42. Dykhuizen R.S., Smith C.C., Kennedy M.M., et al. Necrotizing sarcoid granulomatosis with extrapulmonary involvement. Eur Respir J 10 (1997) 245-247
43. Lazzarini L.C., de Fatima do Amparo Teixeira M., Souza Rodrigues R., et al. Necrotizing sarcoid granulomatosis in a family of patients with sarcoidosis reinforces the association between both entities. Respiration (2007)